
1. pharmacopsychiatry. 2000 mar;33(2):72-4.

schizophrenic psychosis: contraindication treatment hepatitis c with
interferon alpha?

dobmeier m(1), frick e, frank s, franke c, wolfersdorf m.

author information: 
(1)clinic psychiatry psychotherapy university regensburg,
germany. matthias.dobmeier@bzk.uni-regensburg.de

depressive psychotic symptoms well known side-effect interferon alpha
(inf-alpha). therefore, questions arises whether chronic psychosis should
be considered contraindication treatment active hepatitis c with
inf-alpha. report 38-year-old woman chronic schizophrenic
psychosis, acquired chronic aggressive hepatitis c. considering young age
of woman, potential risk developing hepatocellular carcinoma the
result liver biopsy, treatment interferon alpha 2 b (3x5 million
iu/week) started. patient seen three times week, psychiatric
condition monitored using positive negative symptoms score (panss).
no signs psychotic depressive symptoms appeared inf-alpha therapy.
during first 6 months liver enzymes dropped slowly virus load was
increasing. adding ribavirin therapy, liver enzymes dropped
again, pcr carried 9 months initiation 6 months the
end 12 months inf-alpha treatment detect virus rna. this
positive result encourage prospective studies including patients with
these two diagnoses whether patients benefit inf-alpha.

doi: 10.1055/s-2000-8450 
pmid: 10761823  [indexed medline]

